SCM
ZVSA

Saba Capital Management’s ZyVersa Therapeutics ZVSA Stock Holding History

Saba Capital Management’s Portfolio ZVSA Stock Details ZVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,705
Closed -$5.97M – 925
2022
Q3 		$5.97M Buy
1,705
+36
+2% +$126K 0.07% 456
2022
Q2 		$5.8M Buy
1,669
+314
+23% +$1.09M 0.07% 459
2022
Q1 		$4.7M Buy
+1,355
New +$4.7M 0.07% 439